Observational studyBlood advances2026
Long-term experience with emicizumab in people with hemophilia A in the Canadian Bleeding Disorders Registry.
Alfonso Iorio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it